Abbott agrees $1.6bn Depakote settlement - Abbott agrees $1.6bn Depakote settlement Deal marks end of four-year investigation into the selling of the bipolar disorder drug, which was allegedly marketed for unapproved uses Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.